Wikidata

(Q40015124)

English

Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan

scientific article published on September 2007

In more languages

Statements

title
Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
author name string
Yaming Su
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
Peidi Hu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
Sung-Hack Lee
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
Patrick J Sinko
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
publication date
1 September 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017
page(s)
519-536
1 reference
stated in
Europe PubMed Central
PubMed ID
18261372
retrieved
16 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40015124&oldid=1882647379"